GlaxoSmithKline Pharmaceuticals expects approval of audited results

08 Jan 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that the audited results for the year ended December 31, 2012 are expected to be approved by companies board of directors before the end of February 2013 i.e. within a period of 60 days from the close of the accounting year and as such, the company would be announcing the audited financial results within a period of two months of the close of the accounting year.

The company would therefore, not be publishing the un-audited financial results for the quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2380.90 3.25 (0.14%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×